Immunization News and Research

RSS

Pulse EHR receives 2011 CCHIT Comprehensive certification

To receive the 2011 CCHIT Comprehensive certification, the Pulse EHR had to undergo a rigorous inspection of integrated functionality, interoperability and security, in addition to achieving full compliance with proposed federal standards tied to ARRA “meaningful use” financial incentives.

14 Dec 2009

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

14 Dec 2009

Pfizer's Prevenar 13 granted European marketing authorization

The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.

11 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

Macomb County Health Department opens new H1N1 influenza immunization clinics

Sfter holding more than a dozen H1N1 influenza immunization clinics this fall targeting people in high-risk groups, the Macomb County Health Department announced today that it is opening its upcoming clinics to everyone 6 months of age and older.

9 Dec 2009

CPS calls for national child poverty strategy to address disparities in income and opportunities

The Canadian Paediatric Society is calling upon governments at all levels to commit themselves to ending child and youth poverty in Canada. As part of its new report, Are We Doing Enough?, the CPS calls for a national child poverty strategy, with provincial/territorial targets and timetables to address disparities in income and opportunities.

9 Dec 2009

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

The Agence de Médecine Préventive (AMP) has received a three-year grant from the Bill & Melinda Gates Foundation to implement a program to support immunization advocacy in West Africa.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

HHS joins with Ad Council to launch new nationwide PSA campaign

HHS Secretary Kathleen Sebelius announced today that the U.S. Department of Health and Human Services (HHS) is joining with the Ad Council to launch a new nationwide public service advertising (PSA) campaign called “Together We Can All Fight the Flu.”

7 Dec 2009

Measles deaths decline worldwide by 78%, experts warn against complacency

Measles deaths fell from 733,000 in 2000 to 164,000 in 2008 - 78 percent - thanks, in part, to increased vaccination efforts that reached an estimated 700 million children, according to a report released Thursday by the U.S.-based Measles Initiative, Reuters reports.

4 Dec 2009

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority's 2009 December Patient Safety Advisory.

4 Dec 2009

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic.

4 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).

3 Dec 2009

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.

3 Dec 2009

Respiratory syncytial virus, the most common cause of pneumonia in children

RSV is a respiratory virus that infects the lungs and breathing passages. While most healthy people recover from RSV infection, it can be severe in infants. According to the United States Centers for Disease Control and Prevention (CDC), RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the nation.

3 Dec 2009

Phase 1 study of preventive HIV vaccine testing a novel delivery mechanism completed

A Phase 1 study of a preventive HIV vaccine testing a novel delivery mechanism known as electroporation – the use of electrical pulses to increase the immune responses elicited by DNA vaccines – was recently completed in New York City.

1 Dec 2009

NOVAVAX completes patient enrollment in its trivalent seasonal influenza VLP vaccine Phase II study

Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (Fluzone®).

30 Nov 2009

Melvin R. Kaplan to be honored for his lifetime devotion to the care of patients

Melvin R. Kaplan, MD, FACP, a former Board Chair and one of the founders of the research institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be honored by the American College of Physicians for his lifetime devotion to the care of patients.

26 Nov 2009

Americans with hepatitis C are at increased risk of developing liver cancer, says NVHR

New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today.

24 Nov 2009

Immunization News and Research

Pulse EHR receives 2011 CCHIT Comprehensive certification

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

Pfizer's Prevenar 13 granted European marketing authorization

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Macomb County Health Department opens new H1N1 influenza immunization clinics

CPS calls for national child poverty strategy to address disparities in income and opportunities

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

HHS joins with Ad Council to launch new nationwide PSA campaign

Measles deaths decline worldwide by 78%, experts warn against complacency

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

Respiratory syncytial virus, the most common cause of pneumonia in children

Phase 1 study of preventive HIV vaccine testing a novel delivery mechanism completed

NOVAVAX completes patient enrollment in its trivalent seasonal influenza VLP vaccine Phase II study

Melvin R. Kaplan to be honored for his lifetime devotion to the care of patients

Americans with hepatitis C are at increased risk of developing liver cancer, says NVHR

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News